Merck EVP DeLuca sells $5.9M in stock transaction

Merck's (MRK) Executive Vice President, DeLuca, has sold $5.9 million worth of stock. This sale comes as part of a routine exercise of stock options. The transaction is significant as insider selling can sometimes indicate a lack of confidence in the company’s future performance. For investors, such sales can suggest potential caution regarding the stock's short-term outlook, making it important to monitor insider activity.